CIK 0001764013 · Large accelerated filer
Immunovant, Inc.
Sign in to watch- Ticker
- IMVT
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Mar 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 832771572
- Phone
- 917-410-3120
- Business address
- 1000 PARK FORTY PLAZA, DURHAM, NC, 27713
- Former names
- Health Sciences Acquisitions Corp
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $1,030,805
- in 10 filings, $173K under 10b5-1 plans
Net −$1,030,805. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2025-04-09 | Stout Jay S Chief Technology Officer | Sale | −5,004 | $12.99 | $65K | 211,168 |
| 2025-04-09 | Geffner Michael Chief Medical Officer | Sale | −6,169 | $12.99 | $80K | 227,719 |
| 2025-04-09 | Barnett Eva Renee Chief Financial Officer | Sale | −7,013 | $12.99 | $91K | 403,817 |
| 2025-04-09 | Barnett Eva Renee Chief Financial Officer | Sale | −4,050 | $12.99 | $53K | 399,767 |
| 2025-04-09 | Salzmann Peter Chief Executive Officer | Sale | −28,094 | $12.99 | $365K | 1,186,512 |
| 2025-04-01 | Van Tuyl Christopher Chief Legal Officer | Grant or award | +50,787 | 160,743 | ||
| 2025-04-01 | Van Tuyl Christopher Chief Legal Officer | Grant or award · Stock Option (right to buy) | +71,531 | 71,531 | ||
| 2025-04-01 | Gloria Melanie Chief Operating Officer | Grant or award | +76,181 | 186,137 | ||
| 2025-04-01 | Gloria Melanie Chief Operating Officer | Grant or award · Stock Option (right to buy) | +107,297 | 107,297 | ||
| 2025-04-01 | Stout Jay S Chief Technology Officer | Grant or award | +76,181 | 216,172 | ||
| 2025-04-01 | Stout Jay S Chief Technology Officer | Grant or award · Stock Option (right to buy) | +107,297 | 107,297 | ||
| 2025-04-01 | Geffner Michael Chief Medical Officer | Grant or award | +101,574 | 233,888 | ||
| 2025-04-01 | Geffner Michael Chief Medical Officer | Grant or award · Stock Option (right to buy) | +143,063 | 143,063 | ||
| 2025-04-01 | Barnett Eva Renee Chief Financial Officer | Grant or award | +88,878 | 410,830 | ||
| 2025-04-01 | Barnett Eva Renee Chief Financial Officer | Grant or award · Stock Option (right to buy) | +125,180 | 125,180 | ||
| 2025-04-01 | Salzmann Peter Chief Executive Officer | Grant or award | +265,820 | 1,214,606 | ||
| 2025-04-01 | Salzmann Peter Chief Executive Officer | Grant or award · Stock Option (right to buy) | +374,395 | 374,395 | ||
| 2025-04-01 | Pande Atul Director | Grant or award | +16,188 | 102,851 | ||
| 2025-04-01 | Pande Atul Director | Grant or award · Stock Option (right to buy) | +7,600 | 7,600 | ||
| 2025-04-01 | Hughes Douglas J. Director | Grant or award | +16,188 | 135,773 |
Page 8 of 10 · 191 trades